569 participants
Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-04-05
- Start Date:
- 2009-10-31
- Completion:
- 2015-06-30
Conditions
- HER2/Neu Over-expressing Locally Advanced Breast Cancer
- Metastatic Breast Cancer
Interventions
- DRUG